Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro

被引:32
|
作者
Govindan, Suresh [1 ]
Sarkey, Jason [1 ]
Ji, Xiang [1 ]
Sundaresan, Nagalingam R. [2 ]
Gupta, Mahesh P. [2 ]
de Tombe, Pieter P. [1 ]
Sadayappan, Sakthivel [1 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA
[2] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
Proteolysis; Pathogenesis; Muscle contractility; Actin; Acetylation; Ca2+; Transients; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; REGULATORY DOMAIN; HEART-MUSCLE; F-ACTIN; PHOSPHORYLATION; TROPONIN; CONTRACTILITY; ACTIVATION; BIOMARKER;
D O I
10.1007/s10974-012-9292-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia-reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca2+ transients, contractility, and protein-protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca2+ handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca2+ handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0-C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca2+ handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [31] Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay
    Saber, Walid
    Begin, Kelly J.
    Warshaw, David M.
    VanBuren, Peter
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (06) : 1053 - 1061
  • [32] PKA Phosphorylates Serine 307 of Murine Cardiac Myosin Binding Protein-C In Vitro
    Shaffer, Justin F.
    Jia, Weitao
    Leary, Julie A.
    Harris, Samantha P.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 500A - 500A
  • [33] Effects of cardiac myosin binding protein-C on the regulation of interaction of cardiac myosin with thin filament in an in vitro motility assay
    Shchepkin, D. V.
    Kopylova, G. V.
    Nikitina, L. V.
    Katsnelson, L. B.
    Bershitsky, S. Y.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (01) : 159 - 163
  • [34] Cardiac myosin-binding protein-C phosphorylation and cardiac function
    Sadayappan, S
    Gulick, J
    Osinska, H
    Martin, LA
    Hahn, HS
    Dorn, GW
    Klevitsky, R
    Seidman, CE
    Seidman, JG
    Robbins, J
    CIRCULATION RESEARCH, 2005, 97 (11) : 1156 - 1163
  • [35] Development of a qualitative and quantitative detection method for the N-terminal fragment of cardiac myosin-binding protein C
    Yogeswaran, A.
    Lipps, C.
    Keller, T.
    Liebetrau, C.
    Doerr, O.
    Wolter, S.
    Voss, S.
    Kriechbaum, S.
    Aslam, M.
    Sadayappan, S.
    Hamm, C. W.
    Troidl, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 996 - 997
  • [36] Myosin binding protein-C: an essential protein in skeletal and cardiac muscle
    Luther, Pradeep K.
    Vydyanath, Anupama
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2011, 31 (5-6) : 303 - 305
  • [37] Myosin binding protein-C: an essential protein in skeletal and cardiac muscle
    Pradeep K. Luther
    Anupama Vydyanath
    Journal of Muscle Research and Cell Motility, 2011, 31 : 303 - 305
  • [38] Myosin binding protein-C: Enigmatic regulator of cardiac contraction
    Oakley, Cecily E.
    Chamoun, Jean
    Brown, Louise J.
    Hambly, Brett D.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (12): : 2161 - 2166
  • [39] PHOSPHORYLATED CARDIAC MYOSIN BINDING PROTEIN-C ENHANCES LUSITROPY
    Rosas, Paola Cecilia
    Liu, Yang
    Abdalla, Mohamed
    Thomas, Candice
    Kidwell, David
    Kumar, Rajesh
    Baker, Kenneth
    Patel, Bindiya
    Warrens, Chad
    Solaro, R.
    Powers, Patricia
    Moss, Richard
    Tong, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A871 - A871
  • [40] Dynamic Regulation of Contraction by Cardiac Myosin Binding Protein-C
    Harris, Samantha
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 598A - 598A